Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Performer
1767.2000 -14.10 (-0.79%)
NSE May 08, 2025 15:31 PM
Volume: 2.6M
 

logo
Sun Pharmaceutical Industries Ltd.
01 Feb 2025
1767.20
-0.79%
buy
by BOB Capital Markets Ltd.
Target: 2086 | Upside : 18.0%
BOB Capital Markets Ltd.
Domestic sales grew by 14% in Q3FY25 driven partially by volume/new launches and price hikes. Strong domestic sales growth to continue
 
Sun Pharmaceutical I.. has an average target of 2054.00 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes lower, Asian Paints' Q4 revenue misses Forecaster estimates by 3.5%
Trendlyne Marketwatch | 08 May 2025, 04:03PM
Superstar investor portfolios take a hit from market volatility | Screener: Promoters reducing their stakes
The Baseline | 08 May 2025, 12:37AM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022